Neurotensin and Neurotensin Receptors in health and diseases: A brief review

被引:0
|
作者
Mitra, Sankar P. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Surg, Div Urol, 55 Lake Ave North, Worcester, MA 01655 USA
来源
关键词
Alzheimer disease; Analgesia; cAMP; Cancer; cGMP; Dopamine; G-protein; G-protein coupled receptor; Intracellular calcium; IP3; Neurotensin; Neurotensin receptor; pain; Parkinson's disease; Schizophrenia; Sortilin; NEUROMEDIN-N; MESSENGER-RNA; PLASMA NEUROTENSIN; SUBSTANTIA-NIGRA; BREAST-CANCER; SORTILIN/NEUROTENSIN RECEPTOR-3; PERIAQUEDUCTAL GRAY; CANINE NEUROTENSIN; ENTORHINAL CORTEX; BETA-ENDORPHIN;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurotensin (NT), a thirteen amino acid peptide is located primarily in the brain/central nervous system (CNS) and intestine. In brain or CNS, NT acts as a neurotransmitter/neuromodulator whereas in the digestive or gastrointestinal (GI) tract it works like a hormone. The peptide is processed differentially from its precursor in CNS and GI tissues. As a neuromodulator it controls several neuronal actions influencing dopaminergic, GABAergic, serotonergic, glutaminergic and cholinergic neurons. The peptide has a significant role in Schizophrenia, Parkinson disorder, Alzheimers disease, pain/analgesia, eating disorder, tumor growth and inflammation. It also exerts its influences by interacting with itscorresponding receptors. Until now three types of NT receptors (NTR- 1, NTR-2 and NTR-3) are identified for most physiologic effects. Among them, NTR-1 and NTR-2 are the typical G-protein coupled receptors (GPCR) with seven transmembrane (7TM) spanning the cell surface bi-layer whereas NTR-3 is a single transmembrane receptor belonging to the Sortilin family. The recent attention relating to NT-NTR interactions is drawn for several of its important physiologic role in health and diseases. Among them, neurological, analgesic and malignancy are considered to be the major concern.
引用
收藏
页码:7 / 23
页数:17
相关论文
共 50 条
  • [1] Neurotensin and neurotensin receptors
    Vincent, JP
    Mazella, J
    Kitabgi, P
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) : 302 - 309
  • [2] BIOAFFINITY OF RADIOLABELLED NEUROTENSIN AGONIST AND ANTAGONIST TO NEUROTENSIN RECEPTORS
    Chiper, Diana
    Lungu, Valeria
    Barna, Catalina
    Matei, Lidia
    Radu, Mihai
    Bubueanu, George
    Postolache, Cristian
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (5-6): : 463 - 465
  • [3] Oncogenic role of neurotensin and neurotensin receptors in various cancers
    Ouyang, Qing
    Zhou, Ji
    Yang, Wei
    Cui, Hongjuan
    Xu, Minhui
    Yi, Liang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (08): : 841 - 846
  • [4] ANTAGONISTS OF NEUROTENSIN RECEPTORS
    GULLY, D
    MAFFRAND, JP
    SOUBRIE, P
    ROSTENE, W
    KITABGI, P
    LEFUR, G
    THERAPIE, 1995, 50 (01): : 5 - 7
  • [5] Neurotensin and neurotensin receptors: Characteristic, structure-activity relationship and pain modulation-A review
    Kleczkowska, Patrycja
    Lipkowski, Andrzej W.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 716 (1-3) : 54 - 60
  • [6] COMPETITIVE BINDING OF RADIOLABELED NEUROTENSIN AGONIST AND ANTAGONIST TO NEUROTENSIN RECEPTORS
    Chiper, D.
    Lungu, V.
    Purice, M.
    Radu, M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S383 - S383
  • [7] A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer
    Qiu, Shengyang
    Pellino, Gianluca
    Fiorentino, Francesca
    Rasheed, Shahnawaz
    Darzi, Ara
    Tekkis, Paris
    Kontovounisios, Christos
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [8] BINDING OF NEUROTENSIN ANALOGS TO NEUROTENSIN RECEPTORS FROM RAT-BRAIN
    ALDALOU, AR
    IRVINE, GB
    SHAW, C
    GUTHRIE, DJS
    NELSON, J
    WALKER, B
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 : P580 - P580
  • [9] NEUROTENSIN RECEPTORS IN THE RAT BRONCHI
    AAS, P
    HELLE, KB
    REGULATORY PEPTIDES, 1982, 3 (5-6) : 405 - 413
  • [10] Mechanisms of regulation of neurotensin receptors
    Hermans, E
    Maloteaux, JM
    PHARMACOLOGY & THERAPEUTICS, 1998, 79 (02) : 89 - 104